Early onset, family history, pes cavus, diffuse, and homogeneous nerve-conduction velocity slowing without conduction block suggest diagnosis of CMT1A (1); while recurrent weakness, conduction block, and clinical improvement following immunomodulatory treatment favor CIDP (2). Here, PMP22 is linked to Pes cavus.